CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart failure drug put to the test in major chinese Real-World study
Disease control CompletedThis study collected real-world data on vericiguat, a medication for chronic heart failure, in China. Researchers compared 2,400 patients taking vericiguat with similar patients receiving standard care to see which group had fewer hospitalizations and deaths from heart problems. …
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Disease control
Last updated Apr 04, 2026 04:50 UTC
-
Heart drug study aims to speed up treatment for weakened hearts
Disease control CompletedThis study tested whether people with chronic heart failure could safely start taking the medication vericiguat at a higher dose than usual. Researchers wanted to see if starting at 5 mg instead of 2.5 mg would help patients reach the full 10 mg treatment dose faster, potentially…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Heart failure breakthrough: new drug cuts death and hospitalization risk
Disease control CompletedThis large Phase 3 trial tested whether the drug vericiguat could help people with chronic heart failure live longer and avoid hospital stays. Over 6,000 adults with symptomatic heart failure participated, comparing vericiguat against a placebo. The main goal was to see if the dr…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Heart failure drug put to the test in Real-World german patients
Disease control CompletedThis study looked back at health records to see how well a heart failure medicine called vericiguat works for people in everyday German medical care. Researchers analyzed data from 500 adults with chronic heart failure who were newly prescribed the drug between 2021 and 2023. The…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Massive data dive: how does a heart drug perform in real japanese patients?
Knowledge-focused CompletedThis study looked back at existing medical records to learn how a heart failure drug called vericiguat is used and what happens to patients in real-world Japanese clinics and hospitals. Researchers analyzed data from nearly 5,000 adults with chronic heart failure who started taki…
Matched conditions: CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION
Sponsor: Bayer • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC